In the present observational study, we measured the plasma levels of PCSK9 from control (n = 24), HCC patients HCV positive (n = 53) or negative (n = 33), and not HCC patients, positive (n = 73) or negative (n = 19) for HCV for a total of 178 patients. This evidence concerns the gene PCSK9 and hepatocellular carcinoma.